We read with interest the letter to the editor by Oynur et al., we agree that the substantial difference in the interferon (IFN) treatment duration between the two cohorts may have caused difference in some results.(1,2) As we have pointed out in the discussion section of our study, the median duration of 8.7 months was shorter than the currently recommended duration of at least 48 weeks according to guideline of European Association for the Study of the Liver (EASL).
Keyphrases